OSR Holdings, Inc. Share Price
OSRHOSR Holdings, Inc. Stock Performance
Open $0.54 | Prev. Close $0.49 | Circuit Range N/A |
Day Range $0.49 - $0.54 | Year Range $0.38 - $1.79 | Volume 11,596 |
Average Traded $0.50 |
OSR Holdings, Inc. Share Price Chart
About OSR Holdings, Inc.
OSR Holdings, Inc., a healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Switzerland, and South Korea. The company develops immunotherapy products, including VXM01, an immuno-oncology candidate for glioblastoma that is in phase 2 clinical trial, as well as preclinical stage products, such as VXM04 to treat mesothelin; VXM06 for the treatment of Wilms Tumor Protein (WT1); VXM08 for Carcinoembryonic antigen (CEA); and VXM10 for PD-L1. It is also developing design-augmented (DA) biologics comprising DRT-102, a clinical-stage asset for spinal fusion; and DRT-101, a pre-clinical stage asset for osteoarthritis. In addition, the company distributes neurovascular intervention medical device and systems. OSR Holdings, Inc. is based in Bellevue, Washington.
OSR Holdings, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
09-Apr-26 | $0.54 | $0.51 | +0.00% |
09-Apr-26 | $0.54 | $0.51 | +4.73% |
08-Apr-26 | $0.46 | $0.49 | -1.82% |
07-Apr-26 | $0.51 | $0.49 | +0.00% |
06-Apr-26 | $0.51 | $0.49 | -7.30% |
02-Apr-26 | $0.53 | $0.53 | -7.93% |
01-Apr-26 | $0.55 | $0.58 | -2.36% |